Is Androgen Deprivation Therapy Necessary in Intermediate Risk Prostate Cancer Patients Treated in the Dose Escalation Era?
Year: 2011
Type: article
Authors: K.O. Castle, K.E. Hoffman, L.B. Levy, A.K. Lee, S. Choi, Q.N. Nguyen, S.J. Frank, T. Pugh, S.E. McGuire, D.A. Kuban
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funder: National Cancer Institute
OpenAlex ID: W4235870760
